pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Woman travels to Albania for experimental mitochondrial replacement therapy amid global fertility industry concerns

Nov 2, 2026·read at STAT ↗Negative

A STAT reporter detailed a case of a woman named Heidy Willis who, after multiple failed IVF cycles, sought an experimental fertility option abroad.

Willis traveled to Albania to undergo mitochondrial replacement therapy, a technique that swaps her genetic material into an egg donated by another woman so that the donor’s healthy mitochondria support embryo development.

The procedure is not approved in the United States, and agencies that arrange such medical tourism charge patients thousands of dollars to access clinics that offer MRT.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “A STAT reporter on covering MRT as an experimental fertility treatment”

read at STAT ↗
1,327 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADINGUltragenyx Pharmaceutical Inc.
drugs
adrenaline
topics
Cardiology6Oncology2Rare Disease

related stories

  • 1h agoVistagen cuts workforce for second time in 2026BioSpace
  • Oct 13Helen Branswell, whose reporting on infectious diseases and public health drew acclaim, dies at 69STAT
  • Sep 28Opinion: AI is eroding the barriers that kept biological weapons rareSTAT
  • Sep 11Boycott launched against American Diabetes Association includes journalSTAT
  • Aug 11Vaderis hauls in $152M to test an AKT-targeting drugBioPharma Dive